<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR11">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ogura</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Tobinai</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Hatake</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase I/II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma</article-title>
  <source>Cancer Sci</source>
  <year>2014</year>
  <volume>105</volume>
  <fpage>840</fpage>
  <lpage>846</lpage>
  <pub-id pub-id-type="doi">10.1111/cas.12435</pub-id>
  <?supplied-pmid 24814862?>
  <pub-id pub-id-type="pmid">24814862</pub-id>
 </element-citation>
</ref>
